AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Digital Dose Inhalers Market 2019-2023- Evolving Opportunities with AstraZeneca and GlaxoSmithKline | Technavio

November 14, 2019
Digital Dose Inhalers Market 2019-2023- Evolving Opportunities with AstraZeneca and GlaxoSmithKline | Technavio
Digital Dose Inhalers Market 2019-2023- Evolving Opportunities with AstraZeneca and GlaxoSmithKline | Technavio

LONDON--(BUSINESS WIRE)--Nov 14, 2019--

The global digital dose inhalers market size will grow by USD 989.44 million during 2019-2023. This market report provides a detailed analysis of the market by product (metered dose and soft mist inhalers; and dry powder inhalers) and geography (Asia, Europe, North America, and ROW).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005324/en/

Technavio has announced its latest market research report titled global digital dose inhalers market 2019-2023 (Graphic: Business Wire)

To learn more about the global trends impacting the future of market @Request for Free Sample Report

Vendor Landscape

AstraZeneca Plc, GlaxoSmithKline Plc, Novartis AG, OPKO Health Inc., and Teva Pharmaceutical Industries Ltd are among the vendors who have a strong position in the global market. While AptarGroup Inc. Boehringer Ingelheim International GmbH, Glenmark Pharmaceuticals Ltd., OPKO Health Inc., and Pneuma Respiratory Inc. hold a favorable position in the global market.

AstraZeneca Plc. is one the leading vendors in the digital dose inhalers market sphere. The company’s newest product offerings include:

Get A Free Sample Analysis from theDigital Dose Inhalers

GlaxoSmithKline Plc is another leading vendor in the digital dose inhalers market sphere. In line with the global digital dose inhalers market, the company’s newest product offerings include:

Novartis AG is also a leading vendor in the digital dose inhalers market. In line with the global digital dose inhalers market, the company’s newest product offerings include:

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

KEY TOPICS COVERED:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

PART 13: VENDOR ANALYSIS

PART 14: APPENDIX

For more information about this report visithttps://www.technavio.com/report/digital-dose-inhalers-market-industry-analysis

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

Technavio is an international consulting and market research firm dedicated to empowering confident strategic decisions within the medical device, dental, pharmaceutical and more Healthcare industries.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191114005324/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website: https://www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 11/14/2019 05:30 AM/DISC: 11/14/2019 05:30 AM

http://www.businesswire.com/news/home/20191114005324/en